GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,625,000 | -37.6% | 66,702 | -50.8% | 0.01% | -41.7% |
| Q3 2017 | $4,207,000 | -70.4% | 135,511 | -73.9% | 0.01% | -71.4% |
| Q2 2017 | $14,212,000 | -28.6% | 519,622 | -3.8% | 0.04% | -30.0% |
| Q1 2017 | $19,897,000 | +192.1% | 539,944 | +234.2% | 0.06% | +185.7% |
| Q3 2015 | $6,812,000 | – | 161,577 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |